Skip to main content
Spago Nanomedical AB logo

Spago Nanomedical AB — Investor Relations & Filings

Ticker · SPAGO ISIN · SE0004899474 LEI · 549300DNLTVJ4OGO5X40 ST Manufacturing
Filings indexed 0 across all filing types
Latest filing no filings yet
Country SE Sweden
Listing ST SPAGO

About Spago Nanomedical AB

https://spagonanomedical.se/

Spago Nanomedical AB is a clinical-stage company specializing in nanomedicine for the diagnosis and treatment of cancer. The company's development is centered on a proprietary platform of polymeric nanomaterials designed to accumulate in tumor tissue, enabling targeted medical applications. Its portfolio includes two primary projects. The first, SpagoPix (SN132D), is a gadolinium-free contrast agent for magnetic resonance imaging (MRI) aimed at improving the visualization of solid tumors. The second project, Tumorad (177Lu-SN201), is a radionuclide therapy that utilizes the same nanomaterial platform to deliver a therapeutic radioisotope directly to cancer cells, offering a targeted treatment approach intended to minimize damage to healthy tissue.

Recent filings

No filings indexed yet

We are still gathering filings for Spago Nanomedical AB. .

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.